Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is test the safety of Tarceva, find the best dose, and see what
effects (good and bad) it has on you and your colorectal cancer. The effects of Tarceva will
be evaluated in combination with 5-fluorouracil, leucovorin, and irinotecan, with or without
Bevacizumab.